Quick Answer
Genprex, Inc. reported R&D Expense of $9.43 million for fiscal year 2025.
Genprex, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $9.43M | -10.5% |
| 2024 | $10.54M | -40.2% |
| 2023 | $17.62M | +53.1% |
| 2022 | $11.51M | +28.3% |
| 2021 | $8.97M | +22.8% |
| 2020 | $7.30M | +271.3% |
| 2019 | $1.97M | +102.5% |
| 2018 | $971.4K | +235.1% |
| 2017 | $289.9K | -18.3% |
| 2016 | $354.9K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.19M | -20.4% | -12.3% |
| June 30, 2025 | $2.50M | +50.0% | -1.6% |
| March 31, 2025 | $2.54M | -22.4% | -7.8% |
| September 30, 2024 | $2.76M | -40.3% | +65.4% |
| June 30, 2024 | $1.67M | -58.1% | -49.1% |
| March 31, 2024 | $3.27M | -38.3% | -29.1% |
| September 30, 2023 | $4.62M | +46.2% | +16.1% |
| June 30, 2023 | $3.98M | +35.9% | -25.1% |
- Genprex, Inc. showed a decrease of -10.5% in R&D Expense compared to the prior fiscal year.
- Over the 2016–2025 period, Genprex, Inc.’s r&d expense has grown by 2556.9% (from $354.9 thousand to $9.43 million).
- The most recent figure is from Genprex, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: